Brief: Black Diamond Therapeutics Says Size Of Board Got Reduced
Dec 19 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* UPON RESIGNATION OF ROBERT A. INGRAM, SIZE OF BOARD WAS
REDUCED
FROM TEN MEMBERS TO NINE MEMBERS
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox